Yeast expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Yeast expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

GreenBraid destination vector pGBZ1 - PaqCI - Eco31I - spisPink- Eco31I - PaqCI

GreenBraid destination vector pGBZ2 - PaqCI - Eco31I - spisPink- Eco31I - PaqCI

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

GreenBraid reverse destination vector pGBZ1r - PaqCI - Eco31I - spisPink- Eco31I - PaqCI

GreenBraid reverse destination vector pGBZ2r - PaqCI - Eco31I - spisPink- Eco31I - PaqCII

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Mammalian expression plasmid for SARS-CoV-2 S (surface glycoprotein)

Ready-to-use AAV5 particles produced from pOTTC1032 - pAAV EF1a Nuc-flox(mCherry)-EGFP (#112677). In addition to the viral particles, you will also receive purified pOTTC1032 - pAAV EF1a Nuc-flox(mCherry)-EGFP plasmid DNA. EF1a-driven, Cre-dependent color switch. This AAV directs expression of nuclear mCherry in the absence of Cre. In the presence of Cre, nuclear EGFP (and not mCherry) will be expressed. These AAV preparations are suitable purity for injection into animals.